Celgene Corporation (CELG) Nasdaq Global Select
86.27-0.32-0.37%
CloseJanuary 18, 2019

News: updated – 21-Jan 07:01



The Bristol-Myers Celgene Deal, And Other Ideas18-Jan 01:05(SeekingAlpha)

by Daniel Shvartsman It’s a cliche to say mergers and acquisitions (M&A) are a sign of ‘animal spirits’. It’s an old John Maynard Keynes saying, and not literally tied to M&A. I take the cliched usage to mean that if companies are confident enough to splash cash at a premium to wha…

The Week That Was In San Francisco: 2019 Should Be A Great Year For Healthcare Stocks18-Jan 09:27(SeekingAlpha)

There were numerous highlights in the healthcare sector beginning 2019. First, the announced merger of Bristol Myers ( BMY ) and Celgene ( CELG ) will create a strong entity in oncology and hematology, and will be very accretive to Bristol’s earnings per share. Wall Street had driven down Celg…


Celgene teams up with Kyn Therapeutics in cancer18-Jan 07:46(SeekingAlpha)

Celgene (NASDAQ: CELG ) inks a collaboration agreement with privately held Kyn Therapeutics aimed at developing treatments that target immunosuppressive metabolites , molecules that are upregulated in cancer. More news on: Celgene Corporation, Healthcare stocks news, Read more ……

Celgene teams up with Obsidian Therapeutics in cell therapies18-Jan 07:33(SeekingAlpha)

Celgene (NASDAQ: CELG ) will collaborate with privately held Obsidian Therapeutics on the discovery and development of cell therapies based on the latter’s Destabilizing Domain (DD)technology. More news on: Celgene Corporation, Healthcare stocks news, Read more …